Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, December 16, 2021

Long-term psychological consequences of stroke (OX-CHRONIC): A longitudinal study of cognition in relation to mood and fatigue after stroke: Protocol

So you described a problem but did nothing to solve it. In the business world that would be cause for immediate termination.

Long-term psychological consequences of stroke (OX-CHRONIC): A longitudinal study of cognition in relation to mood and fatigue after stroke: Protocol

First Published October 26, 2021 Research Article  https://doi.org/10.1177/23969873211046120

The long-term psychological consequences of stroke and how cognitive problems change over time after the first-year following stroke remain unclear. Particularly, trajectories of domain-specific and domain-general cognitive functions and how cognition interacts with mood, fatigue and quality of life are not well described.

To determine the prevalence, trajectories and wider impact of domain-specific cognitive impairment in long-term stroke survivors, in relation to mood, fatigue and quality of life.

Participants who previously took part in the Oxford Cognitive Screening study, completed the 6-month follow-up with cognitive, mood, fatigue and quality of life assessments and agreed to be contacted for future research will be recruited into OX-CHRONIC. The eligible cohort is between 2- and 9-years post-stroke. Cognition will be assessed with a detailed neuropsychological battery, alongside questionnaire measures of mood, fatigue, activities of daily life and quality of life measures at two timepoints, 1 year apart. Additionally, medical records will be accessed to extract further clinical information about the stroke and patients may opt-in to wear an activity monitor for 1 week to provide fine-grained measures of sleep and activity. The study protocol and study materials were approved by the national ethics committee (REC Ref: 19/SC/0520).

OX-CHRONIC will provide detailed data on the evolving cognitive profiles of stroke survivors over several years post-stroke. Estimates of long-term prevalence as well as the effect of changes in cognitive profiles on mood, fatigue and quality of life will be examined. This study is funded by a Priority Programme Grant from the Stroke Association (SA PPA 18/100032).

Stroke is the second leading cause of death and the third most important cause of disability burden in the world.1,2 There are 1.2 million stroke survivors in the UK, with 100 000 new strokes every year.3 Whilst mortality rates for stroke have decreased, principally due to better acute stroke care,4 this improved stroke survival has resulted in a higher prevalence of chronic stroke survivors.5

Whilst stroke can result in long-lasting physical6 and communication7 impairments, many of the less visible consequences are changes in affected mood,8 wide ranging cognitive impairments912 and fatigue.13 Post-stroke cognitive impairment (PSCI) longer term is extremely common: in the largest ever national survey conducted with over 11,000 stroke survivors, 90% of respondents reported experiencing cognitive problems.14 Whilst observed prevalence data vary depending on the nature of the measures and the included cohort,10,12 almost all stroke survivors suffer at least one cognitive domain deficit9,11 in the early stages post-stroke. Prevalence of cognitive impairment 1 year post-stroke has been estimated at 34%.15,16 Cognitive impairments post-stroke negatively affect the level of social participation,17 mood18 and quality of life,19 over and above the physical impairments and level of disability. Furthermore, a recent systematic review of quantitative studies on the unmet care needs of community-dwelling stroke survivors reported that the most frequently reported unmet needs were in the area of cognition (41.92%), followed by mood (40.13%).20

Post-stroke cognitive impairment is complex. It is currently comprised under the umbrella term of vascular cognitive impairment, defined as impaired cognitive function surpassing what is considered ‘normal’ within the ageing process, occurring in the presence of underlying vascular pathology.21 However, in predicting the natural history of post-stroke cognition, it is important to distinguish between ‘domain specific’ and ‘domain-general’ problems.22 The NICE guidelines for post-stroke cognitive assessment,23 explicitly state to ‘as soon as possible … assess different cognitive domains post-stroke: attention, memory, spatial awareness, apraxia, and perception’. Additionally, the RCP clinical guideline for stroke24 states that each cognitive domain should not be considered in isolation. The Oxford Cognitive Screen (OCS) was designed with these distinct requirements in mind, as it is a domain-specific cognitive screen designed specifically for stroke patients.9,25 Its reach and significance as the routine first-line cognitive screening tool in stroke has been steadily increasing. The OCS has been widely adopted for clinical use within the NHS, as well as various sites internationally, as it has been culturally and language adapted in seven other countries (e.g. 2628) with more currently under development.

Studies concerning detailed domain-specific cognitive impairments initially post-stroke generally demonstrate some improvement over time in specific cognitive domains, such as spatial inattention/neglect,29 aphasia30 and apraxia.31 However, data from the OCS screening study measuring individual domain-specific impairments show significant proportions of lasting impairment32 and similarly, a study investigating cognitive impairment post-stroke using a global cognitive screen found an overall prevalence of 56% at 6 months.33

Additionally, stroke patients are at an increased risk of developing dementia, as a meta-analysis reported 10% develop dementia after first-ever stroke and 33% after recurrent stroke.34 However, in stroke survivors who do not progress to dementia diagnoses, prevalent yet often more subtle impairments are frequently overlooked, perhaps due to some individuals maintaining a degree of personal independence despite poor cognitive recovery. To better understand the nature and trajectories of long-term PSCI, we must delineate cognitive profiles on a fine-grained neuropsychological level and investigate their relation to long-term outcomes.

OX-CHRONIC is a prospective cohort study of stroke survivors who were initially recruited via consecutive sampling in an acute stroke ward and agreed to further assessments during long-term recovery.

More at link.

 

No comments:

Post a Comment